Janus Henderson Group’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
VPM
VCM
S
Janus Henderson Group's NVAX Position: Q1 2026 in Review
Janus Henderson Group held its Novavax (NVAX) position steady in Q1 2026 at 60,815 shares worth $496K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.
Janus Henderson Group first reported a position in NVAX in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.72M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Janus Henderson Group held 60,815 shares of Novavax worth $496K as of Q1 2026.
- Janus Henderson Group left its Novavax share count unchanged in Q1 2026.
- Novavax made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2009 holding.
- Janus Henderson Group first reported a position in Novavax in Q2 2021 and has held it in 19 quarters since.
- Janus Henderson Group's Novavax position peaked at $1.72M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.